Your browser doesn't support javascript.
loading
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma.
Yu, Zhuoya; Ding, Mengfei; Cai, Yiqing; Lu, Tiange; Chen, Xiaomin; Zhou, Xiangxiang; Wang, Xin.
Afiliação
  • Yu Z; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
  • Ding M; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
  • Cai Y; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
  • Lu T; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
  • Chen X; Department of Hematology, Shandong Provincial Hospital, Shandong University, No.324, Jingwu Road, Jinan, 250021, Shandong, China.
  • Zhou X; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. xiangxiangzhou@sdu.edu.cn.
  • Wang X; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, 251006, China. xiangxiangzhou@sdu.edu.cn.
BMC Cancer ; 23(1): 934, 2023 Oct 03.
Article em En | MEDLINE | ID: mdl-37789275

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histonas / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histonas / Linfoma Difuso de Grandes Células B Idioma: En Ano de publicação: 2023 Tipo de documento: Article